Sarepta Therapeutics Announces Third Quarter 2020 Financial Results and Recent Corporate Developments

NEXT STORY
Calithera Biosciences Reports Third Quarter 2020 Financial Results and Recent Highlights
PREV STORY
Ziopharm Oncology Reports Third Quarter 2020 Financial Results and Provides Corporate Update
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Retrophin Announces Publication of Phase 2 DUET Study of Sparsentan for the Treatment of Focal Segmental Glomerulosclerosis in the Journal of the American Society of Nephrology

DUET publication highlighted during Best of ASN Journals session at ASN Kidney Week 2018 ...

author_avatar
NASDAQ Market News

Evelo Biosciences Reports First Quarter Financial Results and Business Highlights

author_avatar
NASDAQ Market News

Biopharma Executive Rick Crowley Joins Novavax as Chief Operations Officer

author_avatar
NASDAQ Market News